Efficacy/Safety of Urogynecology Synthetic Mesh Surgery
Recruiting
Observational Study
Pelvic Organ Prolapse
Stage III and IV High Grade Pelvic Organ Prolapse
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 30 – 100
- Sex
- Female
- Study type
- Observational
- Participants needed
- 150 (estimated)
- Sponsor
- Mackay Medical College · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a retrospective cohort study, aiming at analyzing the efficacy and safety of mesh surgery in pelvic organ prolapse. The synthetic mesh for pelvic organ prolapse include transvaginal mesh or laparotomy, laparoscope, or robotic-assisted laparoscopic sacrocolpopexy with mesh augmentation. The investigators would like to evaluate the efficacy and safety, such as recurrence rates and complicati…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Pelvic organ prolapse patients with objective / subjective voiding dysfunctions
* Underwent surgery for symptomatic POP ≥ stage II (POP-Q system)
Exclusion Criteria:
* Patients with a history of pelvic radiation.
* Patients with a history of vesico-/recto-/urethra-vaginal fi…
Contacts